EWA
ASMB icon

EverSource Wealth Advisors’s Assembly Biosciences ASMB Stock Holding History

EverSource Wealth Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.51K Hold
55
– – ﹤0.01% 3828
2026
Q1 		$1.53K Hold
55
– – ﹤0.01% 3730
2025
Q4 		$1.87K Hold
55
– – ﹤0.01% 3525
2025
Q3 		$1.41K Hold
55
– – ﹤0.01% 3645
2025
Q2 		$997 Hold
55
– – ﹤0.01% 3740
2025
Q1 		$526 Hold
55
– – ﹤0.01% 3440
2024
Q4 		$868 Hold
55
– – ﹤0.01% 3015
2024
Q3 		$833 Hold
55
– – ﹤0.01% 2763
2024
Q2 		$803 Hold
55
– – ﹤0.01% 2782
2024
Q1 		$686 Hold
55
– – ﹤0.01% 2656
2023
Q4 		$545 Buy
+55
New +$523 ﹤0.01% 2508

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

EverSource Wealth Advisors's ASMB Position: Q2 2026 in Review

EverSource Wealth Advisors held its Assembly Biosciences (ASMB) position steady in Q2 2026 at 55 shares worth $1.51K. The position accounts for ﹤0.01% of the portfolio, ranked #3828.

EverSource Wealth Advisors first reported a position in ASMB in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.87K in Q4 2025. 93 funds tracked by Wall St. Rank hold ASMB as of Q2 2026.

  • EverSource Wealth Advisors held 55 shares of Assembly Biosciences worth $1.51K as of Q2 2026.
  • EverSource Wealth Advisors left its Assembly Biosciences share count unchanged in Q2 2026.
  • Assembly Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3828 holding.
  • EverSource Wealth Advisors first reported a position in Assembly Biosciences in Q4 2023 and has held it in 11 quarters since.
  • EverSource Wealth Advisors's Assembly Biosciences position peaked at $1.87K in Q4 2025.
  • 93 funds tracked by Wall St. Rank held Assembly Biosciences as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.